Streamline Health Solutions
STRM
STRM was delisted on the 11th of August, 2025.
40 hedge funds and large institutions have $24.3M invested in Streamline Health Solutions in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
22% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 9
8% more funds holding
Funds holding: 37 → 40 (+3)
0.03% less ownership
Funds ownership: 2.2% → 2.17% (-0.03%)
29% less capital invested
Capital invested by funds: $34.1M → $24.3M (-$9.77M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$263K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$51.1K |
| 3 |
BWM
BerganKDV Wealth Management
Bloomington,
Minnesota
|
+$40.1K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$33.9K |
| 5 |
Renaissance Technologies
New York
|
+$32.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$56K |
| 2 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$53.3K |
| 3 |
TC
TownSquare Capital
Provo,
Utah
|
-$46.7K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$33K |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$29.2K |
STRM Hedge Fund Activity: Q2 2023 in Review
40 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Streamline Health Solutions (STRM) for Q2 2023, worth a combined $24.3M — down 29% from $34.1M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new STRM positions and 2 closed out — a net gain of 3 holders — while 11 added to existing stakes and 9 trimmed.
The largest buyer was UBS Group, adding an estimated $263K. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $56K sold.
- 40 institutional investors held Streamline Health Solutions (STRM) as of Q2 2023, up from 37 in Q1 2023.
- Funds reported $24.3M of Streamline Health Solutions stock for Q2 2023, down 29% quarter-over-quarter.
- 5 funds opened new Streamline Health Solutions positions in Q2 2023 and 2 closed out, a net change of +3 holders.
- The largest Streamline Health Solutions buyer in Q2 2023 was UBS Group, an estimated $263K added.
- The largest Streamline Health Solutions seller in Q2 2023 was Dimensional Fund Advisors, an estimated $56K sold.
Based on aggregated 13F filings for Q2 2023.